Bristol-Myers Squibb Lung Cancer Drug Approved By The FDA

Opdivo from Bristol-Myers Squibb has been previously approved for use as treatment against metastatic melanoma. The drug adds another cancer to its list as the FDA gives it the green light to be prescribed for treating non-small cell lung cancer.